News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|October 25, 2017

Understanding Targeted Therapies

Newsletter

Stay up to date on cancer updates, research and education

Related Content

CLL

Jaypirca Matches Imbruvica's Effectiveness for CLL, With Hints of Long-Term Benefit

ByJason M Broderick

December 7th 2025

follicular lymphoma

Epkinly Combo Effective in Second-Line R/R Follicular Lymphoma

December 7th 2025

story about ponatinib and blinatumomab for ALL

A New Option Without Traditional Chemotherapy for Ph+ ALL

ByAriana Pelosci

December 7th 2025

AML

Azacitidine Plus Venclexta Superior to Chemo in Acute AML

ByJonah Feldman

December 7th 2025

DLBCL

Older Patients With DLBCL May Benefit From First-Line Epkinly Plus R-mini-CHOP

ByKristie L. Kahl

December 7th 2025

Trending on CURE

KRd Improves Progression in Newly Diagnosed Patients With Myeloma

Every FDA Oncology Approval From November 2025

Elrexfio Maintains Responses in Elderly, Frail Patients With Multiple Myeloma

First Annual Blood Cancer Heroes Honors Leaders, Advocates and Survivors

A New Option Without Traditional Chemotherapy for Ph+ ALL

© 2025 MJH Life Sciences^®

All rights reserved.